|
|
|
| Research progress in biofilm prevention and treatment of Staphylococcus aureus |
| ZHENG Yang ZHA He |
| Department of Clinical Laboratory, the Third Affiliated Hospital of Zunyi Medical University, Guizhou Province, Zunyi 563000, China |
|
|
|
Abstract Staphylococcus aureus (SA) has caused many community-acquired and hospital-acquired infections around the world. The formation of biofilm is a kind of survival strategy for bacteria to adapt to their living environment. Under the protection of biofilm, bacteria in biofilm have become tolerant and resistant to antibiotics and the immune responses, making it difficult to treat infections associated with biofilm. Therefore, the prevention and treatment of SA biofilm has always been a research focus. This review summarizes the latest prevention and treatment strategies to eliminate SA biofilm formation and related infections.
|
|
|
|
|
|
[1] Aygül A，?魻ztürk ■，?覶illi FF，et al. Quercetin inhibits swarming motility and activates biofilm production of Proteus mirabilis possibly by interacting with central regulators，metabolic status or active pump proteins [J]. Phytomedicine，2019，57：65-71.
[2] Frassinetti S，Falleni A，Del Carratore R. Effect of itraconazole on Staphylococcus aureus biofilm and extracellular vesicles formation [J]. Microb Pathog，2020，147：104267.
[3] Wu SC，Liu F，Zhu K，et al. Natural Products That Target Virulence Factors in Antibiotic-Resistant Staphylococcus aureus [J]. Agric Food Chem，2019，67（48）：13195-13211.
[4] 郭秋菊，冯安平，陈开明，等.金黄色葡萄球菌生物膜形成过程的研究进展[J].中国当代医药，2020，27（25）：23-26.
[5] Ming D，Wang D，Cao F，et al. Kaempferol Inhibits the Primary Attachment Phase of Biofilm Formation in Staphylococcus aureus [J]. Front Microbiol，2017，8：2263.
[6] Suresh MK，Biswas R，Biswas L. Biswas. An update on recent developments in the prevention and treatment of Staphylococcus aureus biofilms [J]. Int J Med Microbiol，2019，309（1）：1-12.
[7] Mandell JB，Orr S，Koch J，et al. Large variations in clinical antibiotic activity against Staphylococcus aureus biofilms of periprosthetic joint infection isolates [J]. Orthop Res，2019，37（7）：1604-1609.
[8] 郑红霞，蒋琪霞，王建东.慢性伤口细菌生物膜处理方法的研究进展[J].科学养生，2019，22（10）：304-305.
[9] Meeker DG，Beenken KE，Mills WB，et al. Evaluation of Antibiotics Active against Methicillin-Resistant Staphylococcus aureus Based on Activity in an Established Biofilm [J]. Antimicrob Agents Chemother，2016，60（10）：5688-5694.
[10] Lázaro-Díez M，Remuzgo-Martínez S，Rodríguez-Mirones C，et al. Effects of Subinhibitory Concentrations of Ceftaroline on Methicillin-Resistant Staphylococcus aureus （MRSA） Biofilms [J]. PLoS One，2016，11（1）：e0147569.
[11] Tellis M，Joseph J，Khande H，et al. In vitro bactericidal activity of levonadifloxacin（WCK 771）against methicillin-and quinolone-resistant Staphylococcus aureus biofilms [J]. Med Microbiol，2019，68（8）：1129-1136.
[12] She P，Zhou L，Li S，et al. Synergistic Microbicidal Effect of Auranofin and Antibiotics Against Planktonic and Biofilm-Encased S. aureus and E. faecalis [J]. Front Microbiol，2019，10：2453.
[13] Yan Q，Karau MJ，Raval YS，et al. In vitro activity of oritavancin in combination with rifampin or gentamicin against prosthetic joint infection-associated methicillin-resistant Staphylococcus epidermidis biofilms [J]. Antimicrobial Agents，2018，52（5）：608-615.
[14] Fleming D，Chahin L，Rumbaugh K. Glycoside Hydrolases Degrade Polymicrobial Bacterial Biofilms in Wounds [J]. Antimicrob Agents Chemother，2017，61（2）：e01998-16.
[15] Jorge P，Alves D，Pereira MO. Catalysing the way towards antimicrobial effectiveness：A systematic analysis and a new online resource for antimicrobial-enzyme combinations against Pseudomonas aeruginosa and Staphylococcus aureus [J]. Int J Antimicrob Agents，2019，53（5）：598-605.
[16] Fleming D，Rumbaugh KP. Approaches to Dispersing Medical Biofilms [J]. Microorganisms，2017，5（2）：15.
[17] 万佳宏，常佳伟，魏彦琴，等.金黄色葡萄球菌Agr群体感应系统及其抗毒力治疗研究进展[J].中国病原生物学杂志，2020，15（1）：115-118，122.
[18] Liu Q，Wang X，Qin J，et al. The ATP-Dependent Protease ClpP Inhibits Biofilm Formation by Regulating Agr and Cell Wall Hydrolase Sle1 in Staphylococcus aureus [J]. Front Microbiol，2017，7：181.
[19] Ye J，Shao C，Zhang X，et al. Effects of DNaseⅠcoating of titanium on bacteria adhesion and biofilm formation [J]. Mater Sci Eng C Mater Biol Appl，2017，78：738-747.
[20] Bhattacharya M，Wozniak DJ，Stoodley P，et al. Prevention and treatment of Staphylococcus aureus biofilms [J]. Expert Rev Anti Infect Ther，2015，13（12）：1499-1516.
[21] Xu Q，Sun F，Feng W，et al. Effect of DNase Ⅰ on biofilm formation of Staphylococcus aureus [J]. Nan Fang Yi Ke Da Xue Xue Bao，2015，35（9）：1356-1359.
[22] Sugimoto S，Sato F，Miyakawa R，et al. Broad impact of extracellular DNA on biofilm formation by clinically isolated Methicillin-resistant and-sensitive strains of Staphylococcus aureus [J]. Sci Rep，2018，8（1）：2254.
[23] Baidamshina DR，Trizna EY，Holyavka MG，et al. Targeting microbial biofilms using Ficin，a nonspecific plant protease [J]. Sci Rep，2017，7：46068.
[24] Richter K，Van den Driessche F，Coenye T. Innovative approaches to treat Staphylococcus aureus biofilm-related infections [J]. Essays Biochem，2017，61（1）：61-70.
[25] Oliveira IM，Borges A，Borges F，et al. Repurposing ibuprofen to control Staphylococcus aureus biofilms [J]. Eur J Med Chem，2019，166：197-205.
[26] Ooi N，Eady EA，Cove JH，et al. Redox-active compounds with a history of human use：antistaphylococcal action and potential for repurposing as topical antibiofilm agents [J]. Antimicrob Chemother，2015，70（2）：479-88.
[27] Rangel-Vega A，Bernstein LR，Mandujano-Tinoco EA，et al. Drug repurposing as an alternative for the treatment of recalcitrant bacterial infections [J]. Front Microbiol，2015，6：282.
[28] Kelson AB，Carnevali M，Truong-Le V. Gallium-based anti-infectives：targeting microbial iron-uptake mechanisms [J]. Curr Opin Pharmacol，2013，13（5）：707-716.
[29] Richter K，Ramezanpour M，Thomas N，et al. Mind “De GaPP”：in vitro efficacy of deferiprone and gallium-protoporphyrin against Staphylococcus aureus biofilms [J]. Int Forum Allergy Rhinol，2016，6（7）：737-743.
[30] Yadav MK，Chae SW，Im GJ，et al. Eugenol：a phyto-compound effective against methicillin-resistant and methicillin-sensitive Staphylococcus aureus clinical strain biofilms [J]. PLoS One，2015，10（3）：e0119564.
[31] Singh S，Kalia NP，Joshi P，et al. Boeravinone B，A Novel Dual Inhibitor of NorA Bacterial Efflux Pump of Staphylococcus aureus and Human P-Glycoprotein，Reduces the Biofilm Formation and Intracellular Invasion of Bacteria [J]. Front Microbiol，2017，8：1868.
[32] Tagliaferri TL，Jansen M，Horz HP. Fighting Pathogenic Bacteria on Two Fronts：Phages and Antibiotics as Combined Strategy [J]. Front Microbiol，2019，9：22.
[33] Olsen NMC，Thiran E，Hasler T，et al. Synergistic Removal of Static and Dynamic Staphylococcus aureus Biofilms by Combined Treatment with a Bacteriophage Endolysin and a Polysaccharide Depolymerase [J]. Viruses，2018，10（8）：438.
[34] Shahrour H，Ferrer-Espada R，Dandache I，et al. AMPs as Anti-biofilm Agents for Human Therapy and Prophylaxis [J]. Adv Exp Med Biol，2019，1117：257-279.
[35] Koppen BC，Mulder PPG，de Boer L，et al. Synergistic microbicidal effect of cationic antimicrobial peptides and teicoplanin against planktonic and biofilm-encased Staphylococcus aureus [J]. Int J Antimicrob Agents，2019， 53（2）：143-151. |
|
|
|
